Recent content from Joe Carlson
About 39,000 defibrillators and pacemakers are affected by what regulators have classified as a Class 2 recall.
Early study results of 6,000 diabetic patients showed a drop in hospital visits.
Media blitz aims to boost support for a repeal.
Abbott advises patients to get updates at next scheduled doctor visit.
Following tumult in the 1960s and '70s, Bob's sobriety in the 1980s became an example for others.
The California company is developing a treatment for atrial fibrillation.
CEO is setting up shop in Twin Cities, looking to grab part of $20 billion market.
Mpls.-based firm pursuing Boston company's biopsy-free cancer detection tech.
They both focus on round-the-clock monitoring of blood-sugar levels.
Vital Minn. industry sees potential for higher costs, job cuts if tariffs escalate.
Medibio, which has its U.S. headquarters in Savage, is developing apps to diagnose mental-health problems.
A report of a takeover bid by Stryker med-tech firm pushed shares way up.
They vow to appeal company's victory in key Bair Hugger case.
Executives see mix of innovation, lean manufacturing to hit 4 percent annual growth target.
After a design change, Medtronic device reports some initial success.
A power-switching problem can be deadly, according to FDA notice.
NONFICTION: A Wall Street Journal reporter exposes lies at health care company Theranos.
Outcome could affect thousands of other cases that involve the device.
Bair Hugger alleged to contribute to infection; 3M lawyers disagreed.
Strong sales of next-generation insulin pumps for diabetes helped Medtronic PLC surpass investors’ expectations for its latest quarterly results, sending the company’s stock up 2…
"Renal denervation" uses radio-frequency energy in arteries.
The Bair Hugger, a widely used patient warming system from 3M Co., takes center stage in a federal trial scheduled to begin Monday that could affect thousands of patients who came down with serious joint infections after surgery.
Gillette Children's strives for a perfect fit in creating custom devices for young patients.
The company believes Michael Weinstein will bring a new perspective to company's strategies.
The company raised $108 million in its initial public offering, the second biggest for Minnesota in the past year.
The work that Medtronic is doing today stems directly from its co-founder's bold thinking in business and pacemaker engineering, Omar Ishrak says.
Cybersecurity experts look for best practices to thwart unauthorized access.
Company said it plans to resolve lawsuits, IRS disputes later this year.
Columbia Heights is an inner-ring suburban city of 20,158 people at the southernmost tip of Anoka County. The Heights has been a city for 96…
The company hopes that showing the device is effective in treating urethral strictures will lead to FDA approval.
Concern over organic sales growth sends the shares down in early trading
Medtronic CEO touts continual investment in innovation.
The $275M deal gives the device maker products to aid women's health.
Modern health care is pushing makers to think about reimbursement as part of the creation process.
Firm touts $10B market for its sleep apnea device.
Medtronic aims to lower hypertension with procedure, not drugs.
Amplifon will move its U.S. offices from Plymouth to the Fifth Street Towers.
Dr. Laura Mauri will start to transition into the new job in June, and will fully assume the role on Sept. 1.
Ferring says it plans few changes at flourishing Roseville company
Respiratory medical device maker Vyaire Medical plans to close its plant in Plymouth by June 30, eliminating approximately 50 jobs, according to state officials.
Researchers found that a surprising number of the earliest studies on treatments for chronic conditions presented exaggerated results.
Dead patient's mom wins rare appeal in suit over Medtronic's drug pump.
The system creates cardiac maps that can help guide procedures.
Regulators say Monteris hasn't sufficiently addressed safety concerns raised last year.
Potential $406M deal includes NxThera's promising and novel prostate treatment system, Rezum.
Inspector general's report said $4.4M should have been sent to Medicare.
FDA said products could contain undeclared latex, resulting in an unintended allergic reaction.
The Minnetonka medical device maker will keep its ties to state as part of Canada's Laborie Medical Technology.
HeartMate 3 performed better in clinical test than Abbott's older device.
Companies say patients not in danger while pledging vigilance.
Device was invented by St. Jude Medical, which is now part of Abbott Labs.
Company admits to slow reaction to device flaw but says patients weren't at risk.
A Minnesota company has developed a souped-up swim cap that offers competitive swimmers protection in a collision.
Unique collaboration with Pa. health network could improve care, reduce costs.
Investors sent shares of Surmodics up nearly 10 percent on news of the pact.
The Twin Cities area is emerging as a major player in what could become a multibillion dollar industry.
Glucose monitor can be worn on the upper arm.
A test program has yielded promising results at Ebenezer Care Center.
FTC says bulk discounts denied to buying groups for small dental firms; Patterson says the suit is "meritless."
The recall affects 33,000 cases that contain blankets with a design that makes them susceptible to an airflow blockage.
Roseville-based Rebiotix says new measurements can help against "C. diff."
The U.S. attorney's office accuses the Bloomington firm of providing expensive hunting trips and other payments to doctors who might use its products.
Plaintiffs allege Medtronic paid doctors to conceal problems; company vows to fight case.
The company said all divisions posted sales growth in the last quarter.
During a tumultuous childhood in western Minnesota, Troy Quenemoen immersed himself in the world of comic books, where obstacles are always overcome and individual acts…
Rhonda Robb will be COO at medical device maker in New Brighton.
Removing clots up to 16 hours after the stroke can be effective, researchers have found.
Sales growth generated by the Little Canada device maker carried through 2017.
Owners of the Shoreview medical device company pay $7.6M to settle case.
The device is used to treat vessels that are blocked with calcified plaque.
Increased demand for urology treatment is raising expectations at the device firm.
Lawsuit claimed devicemaker defrauded the federal government.
The companies announced the data as an industry conference gathered this week in Las Vegas.
Judge cites lack of evidence showing investors were deliberately misled.
Unless Congress acts, the ACA measure will return this month after a reprieve.
More from Star Tribune